Coetzee Corné, Truter Ilse, Meyer Anneke
Drug Utilization Research Unit (DURU), Faculty of Health Sciences, Nelson Mandela University, Gqeberha, South Africa.
Department of Pharmacy, Faculty of Health Sciences, University of Limpopo, Sovenga, South Africa.
S Afr J Psychiatr. 2022 Apr 14;28:1786. doi: 10.4102/sajpsychiatry.v28i0.1786. eCollection 2022.
Substance use disorders (SUDs) continue to be a public health problem. Attention-deficit/hyperactivity disorder (ADHD) is seen as a risk factor for SUD. Prevalence of alcohol and cannabis use amongst adults with SUD and comorbid ADHD impacts both disorders cognitively and behaviourally.
Our study aimed to compare alcohol and cannabis use between treatment-seeking SUD patients with ADHD and SUD patients without ADHD symptomatology.
Various rehabilitation centres, including the South African National Council on Alcoholism and Drug Dependence (SANCA) Centres, and Private and Provincial Government Substance Abuse Treatment Centres.
A cross-sectional study of adults on drug rehabilitation was conducted. Data on socio-demographic information and alcohol and cannabis use from 185 post-detox inpatients were collected. Diagnoses were based on DSM-IV criteria. Attention-deficit/hyperactivity disorder diagnosis was confirmed by the Diagnostic-Interview for ADHD in Adults (DIVA 2.0). SUD+ADHD ( = 52) and SUD-ADHD ( = 128) groups were compared on alcohol and cannabis use as a function of gender.
No significant differences in the use of alcohol between the SUD+ADHD and SUD-ADHD groups were found. However, the SUD+ADHD group showed increased cannabis consumption. Especially, the SUD+ADHD females showed an earlier age of onset of cannabis use than the SUD-ADHD females and revealed that they use cannabis for a longer period compared with the SUD-ADHD females and SUD+ADHD and SUD-ADHD males.
The results revealed the relationship between ADHD and cannabis use, especially amongst females with ADHD and reinforce the need to consider ADHD in cannabis use SUD in clinical interventions.
物质使用障碍(SUDs)仍然是一个公共卫生问题。注意力缺陷/多动障碍(ADHD)被视为物质使用障碍的一个风险因素。患有物质使用障碍和共病ADHD的成年人中酒精和大麻使用的流行率对这两种障碍的认知和行为都有影响。
我们的研究旨在比较寻求治疗的患有ADHD的物质使用障碍患者和没有ADHD症状的物质使用障碍患者之间的酒精和大麻使用情况。
各种康复中心,包括南非国家酒精和药物依赖委员会(SANCA)中心以及私立和省级政府物质滥用治疗中心。
对接受药物康复治疗的成年人进行了一项横断面研究。收集了185名戒毒后住院患者的社会人口统计学信息以及酒精和大麻使用的数据。诊断基于《精神疾病诊断与统计手册》第四版(DSM-IV)标准。成人ADHD诊断访谈(DIVA 2.0)确认了注意力缺陷/多动障碍的诊断。比较了物质使用障碍+ADHD组(n = 52)和物质使用障碍-ADHD组(n = 128)在酒精和大麻使用方面的性别差异。
在物质使用障碍+ADHD组和物质使用障碍-ADHD组之间未发现酒精使用方面的显著差异。然而,物质使用障碍+ADHD组的大麻消费量有所增加。特别是,物质使用障碍+ADHD组的女性比物质使用障碍-ADHD组的女性大麻使用起始年龄更早,并且显示与物质使用障碍-ADHD组的女性以及物质使用障碍+ADHD组和物质使用障碍-ADHD组的男性相比,她们使用大麻的时间更长。
结果揭示了ADHD与大麻使用之间的关系,尤其是在患有ADHD的女性中,并强调了在临床干预中考虑ADHD在大麻使用物质使用障碍中的必要性。